DAVID R. CLEMMONS,FRANCIS J. CARR,LAURA A. MAILE,MICHAEL NASO,SIMON WILLIAM KEEN,TIMMOTHY D. JONES
申请号：
BR112015004119
公开号：
BR112015004119A2
申请日:
2013.08.30
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention provides an antibody or antigen-binding fragment thereof that binds avß3 integrin, as well as methods of use in the treatment of diseases and disorders. "monoclonal antibodies to improve or inhibit type 1 insulin-like growth factor (igf-1)". The present invention relates to an α-β3 integrin-binding antibody or antigen-binding fragment, as well as methods of use in the treatment of diseases and disorders.abstract the present invention provides an antibody or antigen-binding fragment thereof that binds avß3 integrin, as well as methods of use in the treatment of diseases and disorders. tradução do resumo resumo patente de invenção: "anticorpos monoclonais para melhorar ou inibir o fator de crescimento semelhante à insulina tipo 1 (igf-1)". a presente invenção refere-se a um anticorpo ou fragmento de ligação ao antígeno que se liga à integrina a?ß3, bem como métodos de utilização no tratamento de doenças e distúrbios.
